Evaxion Biotech A/S (NASDAQ: EVAX) Stock Information | RedChip

Evaxion Biotech A/S (NASDAQ: EVAX)


$0.8600
-0.0477 ( -3.91% ) 11.8K

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

Market Data


Open


$0.8600

Previous close


$0.9077

Volume


11.8K

Market cap


$5.05M

Day range


$0.8480 - $0.9110

52 week range


$0.8467 - $13.6100

SEC Filings


Form Type Description Pages Date
6-k Form 6-K 2 Dec 17, 2024
6-k Form 6-K 2 Dec 12, 2024
6-k Form 6-K 2 Dec 09, 2024
6-k Form 6-K 2 Dec 03, 2024
6-k Form 6-K 2 Nov 13, 2024
6-k Form 6-K 2 Nov 13, 2024
6-k Form 6-K 3 Nov 13, 2024
6-k Form 6-K 2 Oct 31, 2024
6-k Form 6-K 2 Oct 28, 2024
6-k Form 6-K 2 Oct 09, 2024

Latest News